
    
      This is an open-label extension study of IONIS-PKK-LRx in up to 24 participants with HAE. The
      length of participation in the study is approximately 68 weeks, which includes an up to
      4-week qualification period, a 52-week treatment period, and a 12-week post-treatment period.
    
  